Status:

COMPLETED

Can Respiratory Rate Predict the Risk of Deterioration of Septic Patients

Lead Sponsor:

PMD Solutions

Collaborating Sponsors:

Esbjerg Hospital - University Hospital of Southern Denmark

Conditions:

Sepsis

Eligibility:

All Genders

18+ years

Brief Summary

The primary objective is to determine if the trend in Respiratory Rate measurements provided by the device under investigation can be used to predict an increase in Sequential/Sepsis-related Organ Fai...

Detailed Description

The primary objective is to determine if the trend in Respiratory Rate measurements provided by the device under investigation can be used to predict an increase in Sequential/Sepsis-related Organ Fai...

Eligibility Criteria

Inclusion

  • Inclusion criteria
  • ≥ 18 Years
  • Admitted for a minimum of 12 hours
  • Have been diagnosed with sepsis
  • Sepsis diagnosis confirmed by documented or suspected infection (ordering of blood culture or other microbiological investigation by the clinician) and ≥1 of the following presenting within the first 4 hours of admission:
  • Fever or hypothermia, Core temperature \> 38.3 or \< 36 °C
  • Heart rate \> 90/min
  • Respiratory rate \> 20/min
  • Altered consciousness/mental state, defined as GCS \< 15
  • Hyperglycemia, (BS \> 6.7 mmol/L non-diabetic)
  • LKC \> 12 \*10\^9 or \< 4\*10\^9,
  • Normal LKC with \> 10 % immature cells,
  • CRP \> highest normal local lab. Interval
  • Hypotension: Systolic BP \<90 mmHg, or drop in systolic BP \> 40
  • Hypoxemia: PaO2 \< 8.5 Kpa or PaO2/FiO2 \< 40 or tissue perfusion: P-lactate \> 1.6
  • Creatinine . 177 µmol/L
  • Acute oliguria (Diuresis per hour ,0.5 ml/kg/t or 45 ml/t in 2 hours)
  • Coagulopathy: Spontaneous INR \> 1.5, or apt \> 60 sec, thrombocytopenia
  • Paralytic ileus (absence of bowel sounds)
  • Hyperbilirubinemia \> 34µmol/L
  • Are willing to voluntarily sign a statement of informed consent to participate in this investigation
  • Exclusion criteria
  • Allergic to medical grade skin adhesive
  • Pregnant women during second and third trimester
  • Continuous long term steroid use. Defined as not using steroids in the 4 weeks previous to enrolment
  • Patients under the influence of substance abuse (drug or alcohol) that may interfere with their ability to cooperate and comply with the investigation procedures
  • Any disorder, including cognitive dysfunction, which would affect the ability to accurately complete questionnaires and freely give full informed consent. This will be determined by the Abbreviated Mental Test Score (AMT) Cannot be followed a second time if admitted again at a later date during the study period

Exclusion

    Key Trial Info

    Start Date :

    March 23 2017

    Trial Type :

    OBSERVATIONAL

    Allocation :

    ACTUAL

    End Date :

    November 21 2017

    Estimated Enrollment :

    132 Patients enrolled

    Trial Details

    Trial ID

    NCT03752047

    Start Date

    March 23 2017

    End Date

    November 21 2017

    Last Update

    November 23 2018

    Active Locations (1)

    Enter a location and click search to find clinical trials sorted by distance.

    Page 1 of 1 (1 locations)

    1

    Hospital of South West Jutland, Department of Emergency Medicine

    Esbjerg, South West Jutland, Denmark, DK-6700